FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 101 through 150 of 324

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
CTNM Nasdaq Contineum Therapeutics, Inc. 2836
CYPH Nasdaq Cypherpunk Technologies Inc. 2836
CYTK Nasdaq Cytokinetics, Incorporated 2836
DCTH Nasdaq Delcath Systems, Inc. 2836
DMAC Nasdaq DiaMedica Therapeutics Inc. 2836
DNA New York Ginkgo Bioworks Holdings, Inc. 2836
DNTH Nasdaq Dianthus Therapeutics, Inc. 2836
DRUG Nasdaq Bright Minds Biosciences Inc. 2836
DSGN Nasdaq Design Therapeutics, Inc. 2836
DYN Nasdaq Dyne Therapeutics, Inc. 2836
ELAB Nasdaq PMGC Holdings Inc. 2836
ELUT Nasdaq Elutia Inc. 2836
ELVN Nasdaq Enliven Therapeutics, Inc. 2836
ENTA Nasdaq Enanta Pharmaceuticals, Inc. 2836
ENTX Nasdaq Entera Bio Ltd. 2836
ENVB Nasdaq Enveric Biosciences, Inc. 2836
EPRX Nasdaq Eupraxia Pharmaceuticals Inc. 2836
EQ Nasdaq Equillium, Inc. 2836
ERAS Nasdaq Erasca, Inc. 2836
ERNA Nasdaq Ernexa Therapeutics Inc. 2836
EVAX Nasdaq Evaxion A/S 2836
EXEL Nasdaq Exelixis, Inc. 2836
EXOZ Nasdaq eXoZymes, Inc. 2836
FATE Nasdaq Fate Therapeutics, Inc. 2836
FBRX Nasdaq Forte Biosciences, Inc. 2836
FDMT Nasdaq 4D Molecular Therapeutics, Inc. 2836
FENC Nasdaq Fennec Pharmaceuticals Inc. 2836
FHTX Nasdaq Foghorn Therapeutics Inc. 2836
FRMM Nasdaq Forum Markets, Incorporated 2836
FRNM Nasdaq Freenome, Inc. 2836
FTH Nasdaq Faeth Therapeutics, Inc. 2836
GALT Nasdaq Galectin Therapeutics Inc. 2836
GANX Nasdaq Gain Therapeutics, Inc. 2836
GENB Nasdaq Generate Biomedicines, Inc. 2836
GHRS Nasdaq GH Research PLC 2836
GLMD Nasdaq Galmed Pharmaceuticals Ltd. 2836
GLSI Nasdaq Greenwich LifeSciences, Inc. 2836
GLUE Nasdaq Monte Rosa Therapeutics, Inc. 2836
GMAB Nasdaq Genmab A/S 2836
GNPX Nasdaq Genprex, Inc. 2836
GNTA Nasdaq Genenta Science S.p.A. 2836
GOSS Nasdaq Gossamer Bio, Inc. 2836
GRAL Nasdaq GRAIL, Inc. 2836
GRI Nasdaq GRI Bio, Inc. 2836
GTBP Nasdaq GT Biopharma, Inc. 2836
HALO Nasdaq Halozyme Therapeutics, Inc. 2836
HBIO Nasdaq Harvard Bioscience, Inc. 2836
HUMA Nasdaq Humacyte, Inc. 2836
HURA Nasdaq TuHURA Biosciences, Inc. 2836
HYFT Nasdaq MindWalk Holdings Corp. 2836
Results 100 through 150 of 324